Scopolamine administration modulates muscarinic, nicotinic and nmda receptor systems

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Falsafi, Soheil Keihan ^a   Deli, Alev ^a   Höger, Harald ^a   Pollak, Arnold ^a   Lubec, Gert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; MUSCARINIC M1 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NICOTINIC RECEPTOR ALPHA4; SCOPOLAMINE; ACETYLCHOLINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC RECEPTOR; SCOPOLAMINE BROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; HIPPOCAMPUS; LEARNING; MALE; MAZE TEST; MEMORY CONSOLIDATION; MEMORY DISORDER; MENTAL PERFORMANCE; MOUSE; NONHUMAN; SPATIAL MEMORY; ANIMAL; ANIMAL BEHAVIOR; BRAIN; C57BL MOUSE; DRUG EFFECT; MEMORY; METABOLISM; METHODOLOGY; MOTOR PERFORMANCE; MOVEMENT (PHYSIOLOGY); NEUROLOGY; PHYSIOLOGY;

MUS;

ACETYLCHOLINE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MOTOR SKILLS; MOVEMENT; MUSCARINIC ANTAGONISTS; NEUROLOGY; RECEPTORS, MUSCARINIC; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; SCOPOLAMINE HYDROBROMIDE;

EID: 84857572969     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032082     Document Type: Article

References (90)

1. Bartus RT, Dean RL 3rd, Beer B, Lippa AS, (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-414.
2. Hulme EC, Birdsall NJ, Burgen AS, Mehta P, (1978) The binding of antagonists to brain muscarinic receptors. Mol Pharmacol 14: 737-750.
3. Schmeller T, Sporer F, Sauerwein M, Wink M, (1995) Binding of tropane alkaloids to nicotinic and muscarinic acetylcholine receptors. Pharmazie 50: 493-495.
4. Barak S, Weiner I, (2009) Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs. Int J Neuropsychopharmacol 12: 227-241.
5. Buccafusco JJ, Terry AV Jr, Webster SJ, Martin D, Hohnadel EJ, et al. (2008) The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates. Psychopharmacology (Berl) 199: 481-494.
6. Cunha GM, Canas PM, Melo CS, Hockemeyer J, Muller CE, et al. (2008) Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801. Exp Neurol 210: 776-781.
7. Loiseau F, Dekeyne A, Millan MJ, (2008) Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex. Psychopharmacology (Berl) 196: 93-104.
8. Vaisman N, Pelled D, (2009) n-3 phosphatidylserine attenuated scopolamine-induced amnesia in middle-aged rats. Prog Neuropsychopharmacol Biol Psychiatry 33: 952-959.
9. Klinkenberg I, Blokland A, (2011) A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment. Psychopharmacology (Berl) 215: 549-566.
10. Boren JJ, Navarro AP, (1959) The action of atropine, benactyzine, and scopolamine upon fixed-interval and fixed-ratio behavior. J Exp Anal Behav 2: 107-115.
11. Hearst E, (1959) Effects of scopolamine on discriminated responding in the rat. J Pharmacol Exp Ther 126: 349-358.
12. Carlton PL, (1963) Cholinergic mechanisms in the control of behavior by the brain. Psychol Rev 70: 19-39.
13. Wiener NI, Messer J, (1973) Scopolamine-induced impairment of long-term retention in rats. Behav Biol 9: 227-234.
14. Brito GN, Davis BJ, Stopp LC, Stanton ME, (1983) Memory and the septo-hippocampal cholinergic system in the rat. Psychopharmacology (Berl) 81: 315-320.
15. Bermudez-Rattoni F, Coburn KL, Fernandez J, Chavez AF, Garcia J, (1987) Potentiation of odor by taste and odor aversions in rats are regulated by cholinergic activity of dorsal hippocampus. Pharmacol Biochem Behav 26: 553-559.
16. Messer WS Jr, Thomas GJ, Hoss W, (1987) Selectivity of pirenzepine in the central nervous system. II. Differential effects of pirenzepine and scopolamine on performance of a representational memory task. Brain Res 407: 37-45.
17. Blokland A, Honig W, Raaijmakers WG, (1992) Effects of intra-hippocampal scopolamine injections in a repeated spatial acquisition task in the rat. Psychopharmacology (Berl) 109: 373-376.
18. Ohno M, Watanabe S, (1996) D-cycloserine, a glycine site agonist, reverses working memory failure by hippocampal muscarinic receptor blockade in rats. Eur J Pharmacol 318: 267-271.
19. Watts J, Stevens R, Robinson C, (1981) Effects of scopolamine on radial maze performance in rats. Physiol Behav 26: 845-851.
20. Eckerman DA, Gordon WA, Edwards JD, MacPhail RC, Gage MI, (1980) Effects of scopolamine, pentobarbital, and amphetamine on radial arm maze performance in the rat. Pharmacol Biochem Behav 12: 595-602.
21. Buresova O, Bolhuis JJ, Bures J, (1986) Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial water maze. Behav Neurosci 100: 476-482.
22. Decker MW, Gill TM, McGaugh JL, (1990) Concurrent muscarinic and beta-adrenergic blockade in rats impairs place-learning in a water maze and retention of inhibitory avoidance. Brain Res 513: 81-85.
23. Saucier D, Hargreaves EL, Boon F, Vanderwolf CH, Cain DP, (1996) Detailed behavioral analysis of water maze acquisition under systemic NMDA or muscarinic antagonism: nonspatial pretraining eliminates spatial learning deficits. Behav Neurosci 110: 103-116.
24. Riekkinen P Jr, Sirvio J, Valjakka A, Pitkanen A, Partanen J, et al. (1990) The effects of concurrent manipulations of cholinergic and noradrenergic systems on neocortical EEG and spatial learning. Behav Neural Biol 54: 204-210.
25. Cain DP, (1998) Testing the NMDA, long-term potentiation, and cholinergic hypotheses of spatial learning. Neurosci Biobehav Rev 22: 181-193.
26. Lieben CK, Blokland A, Sik A, Sung E, van Nieuwenhuizen P, et al. (2005) The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat. Neuropsychopharmacology 30: 2169-2179.
27. Thouvarecq R, Caston J, Protais P, (2007) Cholinergic system, rearing environment and trajectory learning during aging in mice. Physiol Behav 90: 155-164.
28. Harrison FE, Hosseini AH, Dawes SM, Weaver S, May JM, (2009) Ascorbic acid attenuates scopolamine-induced spatial learning deficits in the water maze. Behav Brain Res 205: 550-558.
29. Godding PR, Rush JR, Beatty WW, (1982) Scopolamine does not disrupt spatial working memory in rats. Pharmacol Biochem Behav 16: 919-923.
30. Renner UD, Oertel R, Kirch W, (2005) Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit 27: 655-665.
31. Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama NP, et al. (2003) Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 6: 51-58.
32. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR, (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 11: 3218-3226.
33. Wei J, Walton EA, Milici A, Buccafusco JJ, (1994) m1-m5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC. J Neurochem 63: 815-821.
34. Park SJ, Kim DH, Lee IK, Jung WY, Park DH, et al. (2010) The ameliorating effect of the extract of the flower of Prunella vulgaris var. lilacina on drug-induced memory impairments in mice. Food Chem Toxicol 48: 1671-1676.
35. Bonner TI, Buckley NJ, Young AC, Brann MR, (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science 237: 527-532.
36. Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, et al. (1987) Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. Embo J 6: 3923-3929.
37. Bonner TI, Young AC, Brann MR, Buckley NJ, (1988) Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1: 403-410.
38. Lefkowitz RJ, (2007) Seven transmembrane receptors: something old, something new. Acta Physiol (Oxf) 190: 9-19.
39. Buckley NJ, Bonner TI, Brann MR, (1988) Localization of a family of muscarinic receptor mRNAs in rat brain. J Neurosci 8: 4646-4652.
40. Weiner DM, Levey AI, Brann MR, (1990) Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci U S A 87: 7050-7054.
41. Conn PJ, Jones CK, Lindsley CW, (2009) Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Trends Pharmacol Sci 30: 148-155.
42. Fornari RV, Moreira KM, Oliveira MG, (2000) Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory. Learn Mem 7: 287-292.
43. Kimura Y, Ohue M, Kitaura T, Kihira K, (1999) Amnesic effects of the anticholinergic drugs, trihexyphenidyl and biperiden: differences in binding properties to the brain muscarinic receptor. Brain Res 834: 6-12.
44. Soares JC, Fornari RV, Oliveira MG, (2006) Role of muscarinic M1 receptors in inhibitory avoidance and contextual fear conditioning. Neurobiol Learn Mem 86: 188-196.
45. Roldan G, Bolanos-Badillo E, Gonzalez-Sanchez H, Quirarte GL, Prado-Alcala RA, (1997) Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats. Neurosci Lett 230: 93-96.
46. Wezenberg E, Verkes RJ, Sabbe BG, Ruigt GS, Hulstijn W, (2005) Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects. Psychopharmacology (Berl) 181: 582-594.
47. Caulfield MP, (1993) Muscarinic receptors-characterization, coupling and function. Pharmacol Ther 58: 319-379.
48. Volpicelli LA, Levey AI, (2004) Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res 145: 59-66.
49. Le Novere N, Grutter T, Changeux JP, (2002) Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites. Proc Natl Acad Sci U S A 99: 3210-3215.
50. Rush R, Kuryatov A, Nelson ME, Lindstrom J, (2002) First and second transmembrane segments of alpha3, alpha4, beta2, and beta4 nicotinic acetylcholine receptor subunits influence the efficacy and potency of nicotine. Mol Pharmacol 61: 1416-1422.
51. Lena C, Changeux JP, (1998) Allosteric nicotinic receptors, human pathologies. J Physiol Paris 92: 63-74.
52. Cordero-Erausquin M, Marubio LM, Klink R, Changeux JP, (2000) Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol Sci 21: 211-217.
53. McGehee DS, (1999) Molecular diversity of neuronal nicotinic acetylcholine receptors. Ann N Y Acad Sci 868: 565-577.
54. Hogg RC, Raggenbass M, Bertrand D, (2003) Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol 147: 1-46.
55. Jones S, Sudweeks S, Yakel JL, (1999) Nicotinic receptors in the brain: correlating physiology with function. Trends Neurosci 22: 555-561.
56. Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, et al. (2004) Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 65: 1526-1535.
57. Salminen O, Drapeau JA, McIntosh JM, Collins AC, Marks MJ, et al. (2007) Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. Mol Pharmacol 71: 1563-1571.
58. Marks MJ, Collins AC, (1982) Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Mol Pharmacol 22: 554-564.
59. Whiteaker P, Davies AR, Marks MJ, Blagbrough IS, Potter BV, et al. (1999) An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. Eur J Neurosci 11: 2689-2696.
60. Broide RS, Leslie FM, (1999) The alpha7 nicotinic acetylcholine receptor in neuronal plasticity. Mol Neurobiol 20: 1-16.
61. Wonnacott S, (1997) Presynaptic nicotinic ACh receptors. Trends Neurosci 20: 92-98.
62. Perry DC, Xiao Y, Nguyen HN, Musachio JL, Davila-Garcia MI, et al. (2002) Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. J Neurochem 82: 468-481.
63. Kenney JW, Gould TJ, (2008) Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol 38: 101-121.
64. Marino MJ, Rouse ST, Levey AI, Potter LT, Conn PJ, (1998) Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc Natl Acad Sci U S A 95: 11465-11470.
65. Ghafari M, Patil SS, Hoger H, Pollak A, Lubec G, (2011) NMDA-complexes linked to spatial memory performance in the Barnes maze in CD1 mice. Behav Brain Res 221: 142-148.
66. Li HB, Matsumoto K, Tohda M, Yamamoto M, Watanabe H, (1996) NMDA-but not AMPA-receptor antagonists augment scopolamine-induced spatial cognitive deficit of rats in a radial maze task. Brain Res 725: 268-271.
67. Mrzljak L, Levey AI, Goldman-Rakic PS, (1993) Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission. Proc Natl Acad Sci U S A 90: 5194-5198.
68. Harvey J, Balasubramaniam R, Collingridge GL, (1993) Carbachol can potentiate N-methyl-D-aspartate responses in the rat hippocampus by a staurosporine and thapsigargin-insensitive mechanism. Neurosci Lett 162: 165-168.
69. Jones SV, (1993) Muscarinic receptor subtypes: modulation of ion channels. Life Sci 52: 457-464.
70. Liu L, Zhao R, Bai Y, Stanish LF, Evans JE, et al. (2006) M1 muscarinic receptors inhibit L-type Ca2+ current and M-current by divergent signal transduction cascades. J Neurosci 26: 11588-11598.
71. Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G, (1998) Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation. Eur J Neurosci 10: 2887-2895.
72. Ma L, Seager MA, Wittmann M, Jacobson M, Bickel D, et al. (2009) Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation. Proc Natl Acad Sci U S A 106: 15950-15955.
73. Boddeke EW, Enz A, Shapiro G, (1992) SDZ ENS 163, a selective muscarinic M1 receptor agonist, facilitates the induction of long-term potentiation in rat hippocampal slices. Eur J Pharmacol 222: 21-25.
74. Burgard EC, Sarvey JM, (1990) Muscarinic receptor activation facilitates the induction of long-term potentiation (LTP) in the rat dentate gyrus. Neurosci Lett 116: 34-39.
75. Calabresi P, Centonze D, Gubellini P, Bernardi G, (1999) Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP. Neuropharmacology 38: 323-326.
76. Doralp S, Leung LS, (2008) Cholinergic modulation of hippocampal CA1 basal-dendritic long-term potentiation. Neurobiol Learn Mem 90: 382-388.
77. Kamsler A, McHugh TJ, Gerber D, Huang SY, Tonegawa S, (2010) Presynaptic m1 muscarinic receptors are necessary for mGluR long-term depression in the hippocampus. Proc Natl Acad Sci U S A 107: 1618-1623.
78. Ovsepian SV, Anwyl R, Rowan MJ, (2004) Endogenous acetylcholine lowers the threshold for long-term potentiation induction in the CA1 area through muscarinic receptor activation: in vivo study. Eur J Neurosci 20: 1267-1275.
79. Shinoe T, Matsui M, Taketo MM, Manabe T, (2005) Modulation of synaptic plasticity by physiological activation of M1 muscarinic acetylcholine receptors in the mouse hippocampus. J Neurosci 25: 11194-11200.
80. Ghafari M, Falsafi SK, Hoeger H, Lubec G, (2011) Hippocampal levels of GluR1 and GluR2 complexes are modulated by training in the multiple T-Maze in C57BL/6J mice. Brain Struct Funct in press, DOI:10.1007/s00429-00011-00335-00428.
81. Sase A, Khan D, Hoger H, Lubec G, (2011) Intraperitoneal injection of saline modulates hippocampal brain receptor complex levels but does not impair performance in the Morris Water Maze. Amino Acids in press, DOI:10.1007/s00726-00011-01130-00729.
82. Robinson L, Harbaran D, Riedel G, (2004) Visual acuity in the water maze: sensitivity to muscarinic receptor blockade in rats and mice. Behav Brain Res 151: 277-286.
83. Thouvarecq R, Protais P, Jouen F, Caston J, (2001) Influence of cholinergic system on motor learning during aging in mice. Behav Brain Res 118: 209-218.
84. Irwin S, (1968) Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13: 222-257.
85. Rogers DC, Jones DN, Nelson PR, Jones CM, Quilter CA, et al. (1999) Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res 105: 207-217.
86. Patil SS, Sunyer B, Hoger H, Lubec G, (2009) Evaluation of spatial memory of C57BL/6J and CD1 mice in the Barnes maze, the Multiple T-maze and in the Morris water maze. Behav Brain Res 198: 58-68.
87. Zheng JF, Patil SS, Chen WQ, An W, He JQ, et al. (2009) Hippocampal protein levels related to spatial memory are different in the Barnes maze and in the multiple T-maze. J Proteome Res 8: 4479-4486.
88. Chen P, Li X, Sun Y, Liu Z, Cao R, et al. (2006) Proteomic analysis of rat hippocampal plasma membrane: characterization of potential neuronal-specific plasma membrane proteins. J Neurochem 98: 1126-1140.
89. Kang SU, Fuchs K, Sieghart W, Lubec G, (2008) Gel-based mass spectrometric analysis of recombinant GABA(A) receptor subunits representing strongly hydrophobic transmembrane proteins. J Proteome Res 7: 3498-3506.
90. Welinger C, Ekblad L, (2010) Coomassie Staining as Loading Control in Western Blot Analysis. J Proteome Res 10: 1416-1419.